Guidelines for endoscopic management of non-variceal upper gastrointestinal bleeding

Digestive Endoscopy

Volumn 28, Issue 4, 2016, Pages 363-378

  Fujishiro, Mitsuhiro ^a   Iguchi, Mikitaka ^a   Kakushima, Naomi ^a   Kato, Motohiko ^a   Sakata, Yasuhisa ^a   Hoteya, Shu ^a   Kataoka, Mikinori ^a   Shimaoka, Shunji ^a   Yahagi, Naohisa ^a   Fujimoto, Kazuma ^a  

^a Japan Society for Respiratory Endoscopy   (Japan)

Author keywords

bleeding peptic ulcer; endoscopic examination; endoscopic hemostasis; gastroduodenal ulcer bleeding; upper gastrointestinal bleeding

Indexed keywords

ABSOLUTE ETHANOL; ADRENALIN; ALCOHOL; HEMOGLOBIN; HYPERTONIC SALINE EPINEPHRINE SOLUTION; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG; UREA;

ACUTE PEPTIC GASTRODUODENAL ULCER BLEEDING; ANASTOMOTIC BLEEDING; ANGIODYSPLASIA; AREA UNDER THE CURVE; ARGON PLASMA COAGULATION; ARTERIOVENOUS MALFORMATION; BLEEDING; CLINICAL FEATURE; DIRECT DRUG SPRAYING; DISEASE SEVERITY; ENDOSCOPIC BAND LIGATION; ENDOSCOPIC HEMOSTASIS; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; ENDOSCOPIC THERAPY; EVIDENCE BASED MEDICINE; GLASGOW BLATCHFORD SCORE; HEATER PROBE THERMOCOAGULATION; HEMOSTATIC FORCEPS; HUMAN; INCIDENCE; INJECTION THERAPY; INTENSIVE CARE; INTERNATIONAL NORMALIZED RATIO; MALLORY WEISS SYNDROME; MECHANICAL THERAPY; MEDICAL DECISION MAKING; MEDICAL DEVICE; MORTALITY; NON VARICEAL UPPER GASTROINTESTINAL BLEEDING; PEPTIC ULCER BLEEDING; POST BIOPSY BLEEDING; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREVALENCE; PROTHROMBIN TIME; REBLEEDING; RECEIVER OPERATING CHARACTERISTIC; RENDU OSLER WEBER DISEASE; REVIEW; ROCKALL SCORE; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; THERMAL THERAPY; THERMOCOAGULATION; UPPER GASTROINTESTINAL BLEEDING; UREA BLOOD LEVEL; COMPLICATION; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMOSTASIS; JAPAN;

GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEMOSTASIS, ENDOSCOPIC; HUMANS; JAPAN; PEPTIC ULCER HEMORRHAGE;

EID: 84963585220     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/den.12639     Document Type: Review

References (227)

1. Sonnenberg A,. Time trends of ulcer mortality in Europe. Gastroenterology 2007; 132: 2320-7.
2. Cai S, Garcia Rodriguez LA, Masso-Gonzalez EL, et al., Uncomplicated peptic ulcer in the UK: trends from 1997 to 2005. Aliment. Pharmacol. Ther. 2009; 30: 1039-48.
3. Dutta AK, Chacko A, Balekuduru A, et al., Time trends in epidemiology of peptic ulcer disease in India over two decades. Indian J. Gastroenterol. 2012; 31: 111-5.
4. Xia B, Xia HH, Ma CW, et al., Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Aliment. Pharmacol. Ther. 2005; 22: 243-9.
5. Wu CY, Wu CH, Wu MS, et al., A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H. pylori eradication and proton pump inhibitor use. Clin. Gastroenterol. Hepatol. 2009; 7: 427-31.
6. Ministry of Health, Labour and Welfare. List of statistical surveys conducted by Ministry of Health, Labour and Welfare. [Cited 1 June 2015.] Available from URL: http://www.mhlw.go.jp/toukei-hakusho/toukei/index.html.
7. Ootani H, Iwakiri R, Shimoda R, et al., Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J. Gastroenterol. 2006; 41: 41-6.
8. Nakayama M, Iwakiri R, Hara M, et al., Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy. J. Gastroenterol. 2009; 44: 912-8.
9. Huang JQ, Sridhar S, Hunt RH,. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359: 14-22.
10. Hu PJ, Li YY, Lin HL, et al., Gastric atrophy and regional variation in upper gastrointestinal disease. Am. J. Gastroenterol. 1995; 90: 1102-6.
11. Burstein M, Monge E, Leon-Barua R, et al., Low peptic ulcer and high gastric cancer prevalence in a developing country with a high prevalence of infection by Helicobacter pylori. J. Clin. Gastroenterol. 1991; 13: 154-6.
12. Shiokawa Y, Nobunaga M, Saito T, et al., Epidemiological survey regarding mucosal injury in the upper GI tract by NSAIDs. Ryumachi 1991; 31: 96-111 (In Japanese).
13. Primatesta P, Goldacre MJ, Seagroatt V,. Changing patterns in the epidemiology and hospital care of peptic ulcer. Int. J. Epidemiol. 1994; 23: 1206-17.
14. Higham J, Kang JY, Majeed A,. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut 2002; 50: 460-4.
15. Kang JY, Elders A, Majeed A, et al., Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment. Pharmacol. Ther. 2006; 24: 65-79.
16. Asagi S,. Time trends of medical approach for peptic ulcers in the aged patients from Internists' aspect. Geriatr. Gastroenterol. 2002; 14: 159-66 (in Japanese).
17. Medical Information Network Distribution Service. MINDS Handbook for Clinical Practice Guideline Development 2007. Tokyo: Igakushoin, 2007 (in Japanese).
18. Iwasaki H, Shimura T, Yamada T, et al., Novel nasogastric tube-related criteria for urgent endoscopy in nonvariceal upper gastrointestinal bleeding. Dig. Dis. Sci. 2013; 58: 2564-71.
19. Cheng DW, Lu YW, Teller T, et al., A modified Glasgow Blatchford Score improves risk stratification in upper gastrointestinal bleed: a prospective comparison of scoring systems. Aliment. Pharmacol. Ther. 2012; 36: 782-9.
20. Adamopoulos AB, Baibas NM, Efstathiou SP, et al., Differentiation between patients with acute upper gastrointestinal bleeding who need early urgent upper gastrointestinal endoscopy and those who do not. A prospective study. Eur. Gastroenterol. Hepatol. 2003; 15: 381-7.
21. Blatchford O, Murray WR, Blatchford M,. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 2000; 356: 1318-21.
22. Wilcox CM, Alexander LN, Cotsonis G,. A prospective characterization of upper gastrointestinal hemorrhage presenting with hematochezia. Am. J. Gastroenterol. 1997; 92: 231-5.
23. Srygley FD, Gerardo CJ, Tran T, et al., Does this patient have a severe upper gastrointestinal bleed? JAMA 2012; 307: 1072-9.
24. Matei D, Groza I, Furnea B, et al., Predictors of variceal or nonvariceal source of upper gastrointestinal bleeding. An etiology predictive score established and validated in a tertiary referral center. J. Gastrointest. Liver Dis. 2013; 22: 379-84.
25. Alharbi A, Almadi M, Barkun A, et al., Predictors of a variceal source among patients presenting with upper gastrointestinal bleeding. Can. J. Gastroenterol. 2012; 26: 187-92.
26. Pongprasobchai S, Nimitvilai S, Chasawat J, et al., Upper gastrointestinal bleeding etiology score for predicting variceal and non-variceal bleeding. World J. Gastroenterol. 2009; 15: 1099-104.
27. Zambam de Mattos A, Alves de Mattos A, Daros LF, et al., Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices. Ann. Hepatol. 2013; 12: 810-4.
28. Chawla S, Katz A, Attar BM, et al., Platelet count/spleen diameter ratio to predict the presence of esophageal varices in patients with cirrhosis: a systematic review. Eur. J. Gastroenterol. Hepatol. 2012; 24: 431-6.
29. Cherian JV, Deepak N, Ponnusamy RP, et al., Non-invasive predictors of esophageal varices. Saudi J. Gastroenterol. 2011; 17: 64-8.
30. Barrera F, Riquelme A, Soza A, et al., Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients. Ann. Hepatol. 2009; 8: 325-30.
31. Tacke F, Fiedler K, Trautwein C,. A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease. Scand. J. Gastroenterol. 2007; 42: 374-82.
32. Zaman A, Becker T, Lapidus J, et al., Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch. Intern. Med. 2001; 161: 2564-70.
33. Plevris JN, Dhariwal A, Elton RA, et al., The platelet count as a predictor of variceal hemorrhage in primary biliary cirrhosis. Am. J. Gastroenterol. 1995; 90: 959-61.
34. Rockall TA, Logan RF, Devlin HB, et al., Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet 1996; 347: 1138-40.
35. Saltzman JR, Tabak YP, Hyett BH, et al., A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest. Endosc. 2011; 74: 1215-4.
36. Balaban DV, Strambu V, Florea BG, et al., Predictors for in-hospital mortality and need for clinical intervention in upper GI bleeding: a 5-year observational study. Chirurgia (Bucharest, Romania: 1990) 2014; 109: 48-54.
37. Custodio Lima J, Garcia Montes C, Kibune Nagasako C, et al., Performance of the Rockall scoring system in predicting the need for intervention and outcomes in patients with nonvariceal upper gastrointestinal bleeding in a Brazilian setting: a prospective study. Digestion 2013; 88: 252-7.
38. Cieniawski D, Kuzniar E, Winiarski M, et al., Prognostic value of the Rockall score in patients with acute nonvariceal bleeding from the upper gastrointestinal tract. Przeglad lekarski 2013; 70: 1-5.
39. Wang CH, Chen YW, Young YR, et al., A prospective comparison of 3 scoring systems in upper gastrointestinal bleeding. Am. J. Emerg. Med. 2013; 31: 775-8.
40. Dicu D, Pop F, Ionescu D, et al., Comparison of risk scoring systems in predicting clinical outcome at upper gastrointestinal bleeding patients in an emergency unit. Am. J. Emerg. Med. 2013; 31: 94-9.
41. Laursen SB, Hansen JM, Schaffalitzky de Muckadell OB,. The Glasgow Blatchford score is the most accurate assessment of patients with upper gastrointestinal hemorrhage. Clin. Gastroenterol. Hepatol. 2012; 10: 1130-5.
42. Stanley AJ, Dalton HR, Blatchford O, et al., Multicentre comparison of the Glasgow Blatchford and Rockall Scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage. Aliment. Pharmacol. Ther. 2011; 34: 470-5.
43. Stanley AJ, Ashley D, Dalton HR, et al., Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet 2009; 373: 42-7.
44. Enns RA, Gagnon YM, Barkun AN, et al., Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting. World J. Gastroenterol. 2006; 12: 7779-85.
45. Bryant RV, Kuo P, Williamson K, et al., Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding. Gastrointest. Endosc. 2013; 78: 576-83.
46. Chandra S, Hess EP, Agarwal D, et al., External validation of the Glasgow-Blatchford Bleeding Score and the Rockall Score in the US setting. Am. J. Emerg. Med. 2012; 30: 673-9.
47. Ahn S, Lim KS, Lee YS, et al., Blatchford score is a useful tool for predicting the need for intervention in cancer patients with upper gastrointestinal bleeding. J. Gastroenterol. Hepatol. 2013; 28: 1288-94.
48. Schiefer M, Aquarius M, Leffers P, et al., Predictive validity of the Glasgow Blatchford Bleeding Score in an unselected emergency department population in continental Europe. Eur. J. Gastroenterol. Hepatol. 2012; 24: 382-7.
49. Pang SH, Ching JY, Lau JY, et al., Comparing the Blatchford and pre-endoscopic Rockall score in predicting the need for endoscopic therapy in patients with upper GI hemorrhage. Gastrointest. Endosc. 2010; 71: 1134-40.
50. Srirajaskanthan R, Conn R, Bulwer C, et al., The Glasgow Blatchford scoring system enables accurate risk stratification of patients with upper gastrointestinal haemorrhage. Int. J. Clin. Pract. 2010; 64: 868-74.
51. McLaughlin C, Vine L, Chapman L, et al., The management of low-risk primary upper gastrointestinal haemorrhage in the community: a 5-year observational study. Eur. J. Gastroenterol. Hepatol. 2012; 24: 288-93.
52. Farooq FT, Lee MH, Das A, et al., Clinical triage decision vs risk scores in predicting the need for endotherapy in upper gastrointestinal bleeding. Am. J. Emerg. Med. 2012; 30: 129-34.
53. Stephens JR, Hare NC, Warshow U, et al., Management of minor upper gastrointestinal haemorrhage in the community using the Glasgow Blatchford Score. Eur. J. Gastroenterol. Hepatol. 2009; 21: 1340-6.
54. Chen IC, Hung MS, Chiu TF, et al., Risk scoring systems to predict need for clinical intervention for patients with nonvariceal upper gastrointestinal tract bleeding. Am. J. Emerg. Med. 2007; 25: 774-9.
55. Masaoka T, Suzuki H, Hori S, et al., Blatchford scoring system is a useful scoring system for detecting patients with upper gastrointestinal bleeding who do not need endoscopic intervention. J. Gastroenterol. Hepatol. 2007; 22: 1404-8.
56. Tham TC, James C, Kelly M,. Predicting outcome of acute non-variceal upper gastrointestinal haemorrhage without endoscopy using the clinical Rockall Score. Postgrad. Med. J. 2006; 82: 757-9.
57. Gleeson F, Clarke E, Lennon J, et al., Outcome of accident and emergency room triaged patients with low risk non-variceal upper gastrointestinal haemorrhage. Ir. Med. J. 2006; 99: 114-7.
58. Baradarian R, Ramdhaney S, Chapalamadugu R, et al., Early intensive resuscitation of patients with upper gastrointestinal bleeding decreases mortality. Am. J. Gastroenterol. 2004; 99: 619-22.
59. Hwang JH, Fisher DA, Ben-Menachem T, et al., The role of endoscopy in the management of acute non-variceal upper GI bleeding. Gastrointest. Endosc. 2012; 75: 1132-8.
60. Kanwal F, Barkun A, Gralnek IM, et al., Measuring quality of care in patients with nonvariceal upper gastrointestinal hemorrhage: development of an explicit quality indicator set. Am. J. Gastroenterol. 2010; 105: 1710-8.
61. Japan Gastroenterological Endoscopy Society Postgraduate Education Committee. (eds). Guidelines for Gastroenterological Endoscopy version 3. Tokyo: Igaku Shoin, 2006 (in Japanese).
62. Villanueva C, Colomo A, Bosch A, et al., Transfusion strategies for acute upper gastrointestinal bleeding. N. Engl. J. Med. 2013; 368: 11-21.
63. Wang J, Bao YX, Bai M, et al., Restrictive vs liberal transfusion for upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. World J. Gastroenterol. 2013; 19: 6919-27.
64. Jairath V, Hearnshaw S, Brunskill SJ, et al., Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst. Rev. 2010; CD006613.
65. Jairath V, Kahan BC, Gray A, et al., Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial. Transfus. Med. Rev. 2013; 27: 146-53.
66. Shingina A, Barkun AN, Razzaghi A, et al., Systematic review: the presenting international normalized ratio (INR) as a predictor of outcome in patients with upper nonvariceal gastrointestinal bleeding. Aliment. Pharmacol. Ther. 2011; 33: 1010-8.
67. Jairath V, Kahan BC, Stanworth SJ, et al., Prevalence, management, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding in the United Kingdom. Transfusion 2013; 53: 1069-76.
68. Stainsby D, MacLennan S, Thomas D, et al., Guidelines on the management of massive blood loss. Br. J. Haematol. 2006; 135: 634-41.
69. Razzaghi A, Barkun AN,. Platelet transfusion threshold in patients with upper gastrointestinal bleeding: a systematic review. J. Clin. Gastroenterol. 2012; 46: 482-6.
70. Jairath V, Kahan BC, Logan RF, et al., Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study. Endoscopy 2012; 44: 723-30.
71. Hearnshaw SA, Logan RF, Lowe D, et al., Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit. Gut 2010; 59: 1022-9.
72. Sarin N, Monga N, Adams PC,. Time to endoscopy and outcomes in upper gastrointestinal bleeding. Can. J. Gastroenterol. 2009; 23: 489-93.
73. Sung JJ, Chan FK, Chen M, et al., Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding. Gut 2011; 60: 1170-7.
74. Targownik LE, Murthy S, Keyvani L, et al., The role of rapid endoscopy for high-risk patients with acute nonvariceal upper gastrointestinal bleeding. Can. J. Gastroenterol. 2007; 21: 425-9.
75. Tai CM, Huang SP, Wang HP, et al., High-risk ED patients with nonvariceal upper gastrointestinal hemorrhage undergoing emergency or urgent endoscopy: a retrospective analysis. Am. J. Emerg. Med. 2007; 25: 273-8.
76. Spiegel BM, Vakil NB, Ofman JJ,. Endoscopy for acute nonvariceal upper gastrointestinal tract hemorrhage: is sooner better? A systematic review. Arch. Intern. Med. 2001; 161: 1393-404.
77. Asaki S, Nishimura T, Iwai S, et al., Trial of 99.5% ethanol local injection for hemostasis in the GI tract. Gastroenterol. Endosc. 1981; 23: 792-9 (in Japanese).
78. Asaki S,. Pure ethanol local injection for hemostasis. Institute for advanced medical technology. Tokyo, 2002; 50-3. (in Japanese)
79. Hirao M, Yamazaki H, Masuda K, et al., Local injection therapy by using hypertonic saline-epinephrine solution. Stom. Intest. 1980; 15: 751-5 (in Japanese).
80. Hirao M, Kobayashi T, Masuda K, et al., Endoscopic local injection therapy by using hypertonic saline-epinephrine solution: basic examination. Gastroenterol. Endosc. 1981; 23: 1097-107 (in Japanese).
81. Hirao M, Imai K, Yamaguchi O,. Local injection therapy by using hypertonic saline-epinephrine (HSE) solution. In:, Saigenji K, (ed). Endoscopic Handbook for Gastrointestinal Hemorrhage. Tokyo: Chugai Medical Co., 1997; 132-8 (in Japanese).
82. Hayashi T, Yonezawa M, Kuwahara T, et al., Innovation and application of endoclips for hemostasis. Gastroenterol. Endosc. 1975; 17: 92-101 (in Japanese).
83. Hachisu T, Nakao T, Suzuki N, et al., Application of innovated endoclips for upper GI hemorrhage. Gastroenterol. Endosc. 1985; 27: 276-81 (in Japanese).
84. Hachisu T, Yamada H, Sato S, et al., Clip methods for further application in upper GI bleeding. Digestiva Endoscopia 1996; 8: 1205-7 (in Japanese).
85. Nikolaidis N, Zezos P, Giouleme O, et al., Endoscopic band ligation of Dieulafoy-like lesions in the upper gastrointestinal tract. Endoscopy 2001; 33: 754-60.
86. Grund KE, Storek D, Farin G,. Endoscopic argon plasma coagulation (APC) first clinical experiences in flexible endoscopy. Endosc. Surg. Allied Technol. 1994; 2: 42-6.
87. Protell RL, Rubin CE, Auth DC, et al., The heater probe: a new endoscopic method for stopping massive gastrointestinal bleeding. Gastroenterology 1978; 74: 257-62.
88. Laine L, McQuaid KR,. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin. Gastroenterol. Hepatol. 2009; 7: 33-47 quiz 1-2.
89. Barkun AN, Martel M, Toubouti Y, et al., Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest. Endosc. 2009; 69: 786-99.
90. Yuan Y, Wang C, Hunt RH,. Endoscopic clipping for acute nonvariceal upper-GI bleeding: a meta-analysis and critical appraisal of randomized controlled trials. Gastrointest. Endosc. 2008; 68: 339-51.
91. Enestvedt BK, Gralnek IM, Mattek N, et al., Endoscopic therapy for peptic ulcer hemorrhage: practice variations in a multi-center U.S. consortium. Dig. Dis. Sci. 2010; 55: 2568-76.
92. Sung JJ, Tsoi KK, Lai LH, et al., Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut 2007; 56: 1364-73.
93. Pescatore P, Jornod P, Borovicka J, et al., Epinephrine versus epinephrine plus fibrin glue injection in peptic ulcer bleeding: a prospective randomized trial. Gastrointest. Endosc. 2002; 55: 348-53.
94. Lin HJ, Hsieh YH, Tseng GY, et al., A prospective, randomized trial of large-versus small-volume endoscopic injection of epinephrine for peptic ulcer bleeding. Gastrointest. Endosc. 2002; 55: 615-9.
95. Ljubicic N, Budimir I, Biscanin A, et al., Endoclips vs large or small-volume epinephrine in peptic ulcer recurrent bleeding. World J. Gastroenterol. 2012; 18: 2219-24.
96. Park CH, Joo YE, Kim HS, et al., A prospective, randomized trial comparing mechanical methods of hemostasis plus epinephrine injection to epinephrine injection alone for bleeding peptic ulcer. Gastrointest. Endosc. 2004; 60: 173-9.
97. Lo CC, Hsu PI, Lo GH, et al., Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers. Gastrointest. Endosc. 2006; 63: 767-73.
98. Calvet X, Vergara M, Brullet E, et al., Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers. Gastroenterology 2004; 126: 441-50.
99. Koyama T, Fujimoto K, Iwakiri R, et al., Prevention of recurrent bleeding from gastric ulcer with a nonbleeding visible vessel by endoscopic injection of absolute ethanol: a prospective, controlled trial. Gastrointest. Endosc. 1995; 42: 128-31.
100. Shimoda R, Iwakiri R, Sakata H, et al., Evaluation of endoscopic hemostasis with metallic hemoclips for bleeding gastric ulcer: comparison with endoscopic injection of absolute ethanol in a prospective, randomized study. Am. J. Gastroenterol. 2003; 98: 2198-202.
101. Marmo R, Rotondano G, Piscopo R, et al., Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am. J. Gastroenterol. 2007; 102: 279-89.
102. Cipolletta L, Bianco MA, Marmo R, et al., Endoclips versus heater probe in preventing early recurrent bleeding from peptic ulcer: a prospective and randomized trial. Gastrointest. Endosc. 2001; 53: 147-51.
103. Lin HJ, Hsieh YH, Tseng GY, et al., A prospective, randomized trial of endoscopic hemoclip versus heater probe thermocoagulation for peptic ulcer bleeding. Am. J. Gastroenterol. 2002; 97: 2250-4.
104. Chou YC, Hsu PI, Lai KH, et al., A prospective, randomized trial of endoscopic hemoclip placement and distilled water injection for treatment of high-risk bleeding ulcers. Gastrointest. Endosc. 2003; 57: 324-8.
105. Nagata S, Kimura S, Ogoshi H, et al., Endoscopic hemostasis of gastric ulcer bleeding by hemostatic forceps coagulation. Dig. Endosc. 2010; 22 (Suppl 1): S22-5.
106. Fujishiro M, Abe N, Endo M, et al., Retrospective multicenter study concerning electrocautery forceps with soft coagulation for nonmalignant gastroduodenal ulcer bleeding in Japan. Dig. Endosc. 2010; 22 (Suppl 1): S15-8.
107. Arima S, Sakata Y, Ogata S, et al., Evaluation of hemostasis with soft coagulation using endoscopic hemostatic forceps in comparison with metallic hemoclips for bleeding gastric ulcers: a prospective, randomized trial. J. Gastroenterol. 2010; 45: 501-5.
108. Leontiadis GI, Sharma VK, Howden CW,. Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay-results from the Cochrane Collaboration. Aliment. Pharmacol. Ther. 2005; 22: 169-74.
109. Selby NM, Kubba AK, Hawkey CJ,. Acid suppression in peptic ulcer haemorrhage: a meta-analysis. Aliment. Pharmacol. Ther. 2000; 14: 1119-26.
110. Lau JY, Sung JJ, Lee KK, et al., Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N. Engl. J. Med. 2000; 343: 310-6.
111. Zargar SA, Javid G, Khan BA, et al., Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial. J. Gastroenterol. Hepatol 2006; 21: 716-21.
112. Andriulli A, Annese V, Caruso N, et al., Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses. Am. J. Gastroenterol. 2005; 100: 207-19.
113. Jensen DM, Ahlbom H, Eklund S, et al., Rebleeding Risk for Oozing Peptic Ulcer Bleeding (PUB) in a Large International Study-A Reassessment Based Upon a Multivariate Analysis. Gastrointest. Endosc. 2010; 71: AB117.
114. Chen CC, Lee JY, Fang YJ, et al., Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers. Aliment. Pharmacol. Ther. 2012; 35: 894-903.
115. Andriulli A, Loperfido S, Focareta R, et al., High-versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study. Am. J. Gastroenterol. 2008; 103: 3011-8.
116. Jensen DM, Pace SC, Soffer E, et al., Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study. Am. J. Gastroenterol. 2006; 101: 1991-9.
117. van Rensburg C, Barkun AN, Racz I, et al., Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial. Aliment. Pharmacol. Ther. 2009; 29: 497-507.
118. Sakurada T, Kawashima J, Ariyama S, et al., Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers. Dig. Endosc. 2012; 24: 93-9.
119. Kikkawa A, Iwakiri R, Ootani H, et al., Prevention of the rehaemorrhage of bleeding peptic ulcers: effects of Helicobacter pylori eradication and acid suppression. Aliment. Pharmacol. Ther. 2005; 21 (Suppl 2): 79-84.
120. Lin HJ, Lo WC, Cheng YC, et al., Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial. Am. J. Gastroenterol. 2006; 101: 500-5.
121. Kamada T, Hata J, Kusunoki H, et al., Effect of famotidine on recurrent bleeding after successful endoscopic treatment of bleeding peptic ulcer. Aliment. Pharmacol. Ther. 2005; 21 (Suppl 2): 73-8.
122. Marmo R, Rotondano G, Bianco MA, et al., Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis. Gastrointest. Endosc. 2003; 57: 62-7.
123. El Ouali S, Barkun AN, Wyse J, et al., Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis. Gastrointest. Endosc. 2012; 76: 283-92.
124. Chiu PW, Lam CY, Lee SW, et al., Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial. Gut 2003; 52: 1403-7.
125. Tsoi KK, Chan HC, Chiu PW, et al., Second-look endoscopy with thermal coagulation or injections for peptic ulcer bleeding: a meta-analysis. J. Gastroenterol. Hepatol. 2010; 25: 8-13.
126. Ishikawa S, Inaba T, Wato M, et al., Exposed blood vessels of more than 2 mm in diameter are a risk factor for rebleeding after endoscopic clipping hemostasis for hemorrhagic gastroduodenal ulcer. Dig. Endosc. 2013; 25: 13-9.
127. Garcia-Iglesias P, Villoria A, Suarez D, et al., Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer. Aliment. Pharmacol. Ther. 2011; 34: 888-900.
128. Hu ML, Wu KL, Chiu KW, et al., Predictors of rebleeding after initial hemostasis with epinephrine injection in high-risk ulcers. World J. Gastroenterol. 2010; 16: 5490-5.
129. Cheng CL, Lin CH, Kuo CJ, et al., Predictors of rebleeding and mortality in patients with high-risk bleeding peptic ulcers. Dig. Dis. Sci. 2010; 55: 2577-83.
130. Brullet E, Campo R, Calvet X, et al., A randomized study of the safety of outpatient care for patients with bleeding peptic ulcer treated by endoscopic injection. Gastrointest. Endosc. 2004; 60: 15-21.
131. Elmunzer BJ, Young SD, Inadomi JM, et al., Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am. J. Gastroenterol. 2008; 103: 2625-32 quiz 33.
132. Amano Y, Moriyama N, Suetsugu H, et al., Which types of non-bleeding visible vessels in gastric peptic ulcers should be treated by endoscopic hemostasis? J. Gastroenterol. Hepatol. 2004; 19: 13-7.
133. Hepworth CC, Newton M, Barton S, et al., Randomized controlled trial of early feeding in patients with bleeding peptic ulcer and a visible vessel. Gastroenterology 1995; 108: A113.
134. Khoshbaten M, Ghaffarifar S, Jabbar Imani A, et al., Effects of early oral feeding on relapse and symptoms of upper gastrointestinal bleeding in peptic ulcer disease. Dig. Endosc. 2013; 25: 125-9.
135. Cheung FK, Lau JY,. Management of massive peptic ulcer bleeding. Gastroenterol. Clin. North Am. 2009; 38: 231-43.
136. Loffroy R, Rao P, Ota S, et al., Embolization of acute nonvariceal upper gastrointestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc. Intervent. Radiol. 2010; 33: 1088-100.
137. Ripoll C, Banares R, Beceiro I, et al., Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure. J. Vasc. Interv. Radiol. 2004; 15: 447-50.
138. Eriksson LG, Ljungdahl M, Sundbom M, et al., Transcatheter arterial embolization versus surgery in the treatment of upper gastrointestinal bleeding after therapeutic endoscopy failure. J. Vasc. Interv. Radiol. 2008; 19: 1413-8.
139. Rockall TA, Logan RF, Devlin HB, et al., Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995; 311: 222-6.
140. Okada M, Aono R, Nagayoshi Y, et al., Endoscopic hemostasis for Mallory- eiss syndrome. Digestiva Endoscopia 2001; 13: 1782-7 (in Japanese).
141. Shimoda R, Iwakiri R, Sakata H, et al., Endoscopic hemostasis with metallic hemoclips for iatrogenic Mallory-Weiss tear caused by endoscopic examination. Dig. Endosc. 2009; 21: 20-3.
142. Chung IK, Kim EJ, Hwang KY, et al., Evaluation of endoscopic hemostasis in upper gastrointestinal bleeding related to Mallory-Weiss syndrome. Endoscopy 2002; 34: 474-9.
143. Yamaguchi Y, Yamato T, Katsumi N, et al., Endoscopic hemoclipping for upper GI bleeding due to Mallory-Weiss syndrome. Gastrointest. Endosc. 2001; 53: 427-30.
144. Terada R, Ito S, Akama F, et al., Mallory-Weiss syndrome with severe bleeding: treatment by endoscopic ligation. Am. J. Emerg. Med. 2000; 18: 812-5.
145. Higuchi N, Akahoshi K, Sumida Y, et al., Endoscopic band ligation therapy for upper gastrointestinal bleeding related to Mallory-Weiss syndrome. Surg. Endosc. 2006; 20: 1431-4.
146. Cho YS, Chae HS, Kim HK, et al., Endoscopic band ligation and endoscopic hemoclip placement for patients with Mallory-Weiss syndrome and active bleeding. World J. Gastroenterol. 2008; 14: 2080-4.
147. Huang SP, Wang HP, Lee YC, et al., Endoscopic hemoclip placement and epinephrine injection for Mallory-Weiss syndrome with active bleeding. Gastrointest. Endosc. 2002; 55: 842-6.
148. Park CH, Min SW, Sohn YH, et al., A prospective, randomized trial of endoscopic band ligation vs. epinephrine injection for actively bleeding Mallory-Weiss syndrome. Gastrointest. Endosc. 2004; 60: 22-7.
149. Matsui S, Kamisako T, Kudo M, et al., Endoscopic band ligation for control of nonvariceal upper GI hemorrhage: comparison with bipolar electrocoagulation. Gastrointest. Endosc. 2002; 55: 214-8.
150. Fujisawa N, Inamori M, Sekino Y, et al., Risk factors for mortality in patients with Mallory-Weiss syndrome. Hepatogastroenterology 2011; 58: 417-20.
151. Tono S, Morita Y, Miura Y, et al., Safety of endoscopic biopsy under continuation of anti-platelet therapy. Gastroenterol. Endosc. 2011; 53: 3317-25 (in Japanese).
152. Shiffman ML, Farrel MT, Yee YS,. Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDS. Gastrointest. Endosc. 1994; 40: 458-62.
153. Nishimura Y, Michida M, Ikeda M,. Massive bleeding related to endoscopic biopsy in the stomach. Digestiva Endoscopia 2003; 15: 1362-3 (in Japanese).
154. Asagi S, Massive bleeding after endoscopic biopsy to gastric leiomyosarcoma. Digestiva Endoscopia 2003; 15: 236-7 (in Japanese).
155. Ono H, Yao K, Fujishiro M, et al., Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig. Endosc. 2016; 28: 3-15.
156. Enomoto S, Yahagi N, Fujishiro M, et al., Novel endoscopic hemostasis technique for use during endoscopic submucosal dissection. Endoscopy 2007; 39 (Suppl 1) E156.
157. Enomoto S, Yahagi N, Fujishiro M, et al., Assessment of intraoperative bleeding during endoscopic submucosal dissection and endoscopic hemostasis using high-frequency hemostatic forceps. J. Wakayama Med. Soc. 2009; 60: 124-9.
158. Muraki Y, Enomoto S, Iguchi M, et al., Management of bleeding and artificial gastric ulcers associated with endoscopic submucosal dissection. World J. Gastrointest. Endosc. 2012; 4: 1-8.
159. Matsui N, Sugi M, Bai X, et al., Effective hemostasis with hypertonic saline-epinephrine solution for uncontrolled bleeding during endoscopic submucosal dissection of the stomach. Dig. Endosc. 2012; 24: 476.
160. Oda I, Gotoda T, Hamanaka H, et al., Endoscopic submucosal dissection for early gastric cancer: Technical feasibility, operation time and complications from a large consecutive series. Dig. Endosc. 2005; 17: 54-8.
161. Takizawa K, Oda I, Gotoda T, et al., Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection-an analysis of risk factors. Endoscopy 2008; 40: 179-83.
162. Mukai S, Cho S, Nakamura S, et al., Postprocedural combined treatment using the coagulation plus artery-selective clipping (2C) method for the prevention of delayed bleeding after ESD. Surg. Endosc. 2013; 27: 1292-301.
163. Kakushima N, Yahagi N, Fujishiro M, et al., The healing process of gastric artificial ulcers after endoscopic submucosal dissection. Dig. Endosc. 2004; 16: 327-31.
164. Lee SY, Kim JJ, Lee JH, et al., Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. Gastrointest. Endosc. 2004; 60: 213-7.
165. Niimi K, Fujishiro M, Goto O, et al., Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection. Dig. Endosc. 2012; 24: 110-6.
166. Kawano S, Okada H, Kawahara Y, et al., Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial. Digestion 2011; 84: 46-53.
167. Yamaguchi Y, Katsumi N, Tauchi M, et al., A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration. Aliment. Pharmacol. Ther. 2005; 21 (Suppl 2): 111-5.
168. Ye BD, Cheon JH, Choi KD, et al., Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial. Aliment. Pharmacol. Ther. 2006; 24: 837-43.
169. Uedo N, Takeuchi Y, Yamada T, et al., Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am. J. Gastroenterol. 2007; 102: 1610-6.
170. Jeong HK, Park CH, Jun CH, et al., A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection. J. Korean Med. Sci. 2007; 22: 1055-9.
171. Yang Z, Wu Q, Liu Z, et al., Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials. Digestion 2011; 84: 315-20.
172. Imaeda H, Hosoe N, Suzuki H, et al., Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia. J. Gastroenterol. 2011; 46: 1267-72.
173. Tomita T, Kim Y, Yamasaki T, et al., Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection. J. Gastroenterol. Hepatol. 2012; 27: 1441-6.
174. Ohya TR, Endo H, Kawagoe K, et al., A prospective randomized trial of lafutidine vs rabeprazole on post-ESD gastric ulcers. World J. Gastrointest. Endosc 2010; 2: 36-40.
175. Asakuma Y, Kudo M, Matsui S, et al., Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)-induced ulcers in early gastric cancer: prospective randomized study. Hepatogastroenterology 2009; 56: 1270-3.
176. Kato T, Araki H, Onogi F, et al., Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection-a randomized controlled study. J. Gastroenterol. 2010; 45: 285-90.
177. Inaba T, Ishikawa S, Toyokawa T, et al., Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors, and the suppressive effects of polaprezinc. Hepatogastroenterology 2010; 57: 678-84.
178. Fujiwara S, Morita Y, Toyonaga T, et al., A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection. J. Gastroenterol. 2011; 46: 595-602.
179. Huang Y, Kakushima N, Takizawa K, et al., Risk factors for recurrence of artificial gastric ulcers after endoscopic submucosal dissection. Endoscopy 2011; 43: 236-9.
180. Jang JS, Choi SR, Graham DY, et al., Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesions. Scand. J. Gastroenterol. 2009; 44: 1370-6.
181. Mannen K, Tsunada S, Hara M, et al., Risk factors for complications of endoscopic submucosal dissection in gastric tumors: analysis of 478 lesions. J. Gastroenterol. 2010; 45: 30-6.
182. Tsuji Y, Ohata K, Ito T, et al., Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions. World J. Gastroenterol. 2010; 16: 2913-7.
183. Okada K, Yamamoto Y, Kasuga A, et al., Risk factors for delayed bleeding after endoscopic submucosal dissection for gastric neoplasm. Surg. Endosc. 2011; 25: 98-107.
184. Higashiyama M, Oka S, Tanaka S, et al., Risk factors for bleeding after endoscopic submucosal dissection of gastric epithelial neoplasm. Dig. Endosc. 2011; 23: 290-5.
185. Miyahara K, Iwakiri R, Shimoda R, et al., Perforation and postoperative bleeding of endoscopic submucosal dissection in gastric tumors: analysis of 1190 lesions in low- and high-volume centers in Saga, Japan. Digestion 2012; 86: 273-80.
186. Nakamura M, Nishikawa J, Hamabe K, et al., Risk factors for delayed bleeding from endoscopic submucosal dissection of gastric neoplasms. Scand. J. Gastroenterol. 2012; 47: 1108-14.
187. Toyokawa T, Inaba T, Omote S, et al., Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions. J. Gastroenterol. Hepatol 2012; 27: 907-12.
188. Jeon SW, Jung MK, Cho CM, et al., Predictors of immediate bleeding during endoscopic submucosal dissection in gastric lesions. Surg. Endosc. 2009; 23: 1974-9.
189. Ono S, Fujishiro M, Niimi K, et al., Technical feasibility of endoscopic submucosal dissection for early gastric cancer in patients taking anti-coagulants or anti-platelet agents. Dig. Liver Dis. 2009; 41: 725-8.
190. Lim JH, Kim SG, Kim JW, et al., Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms? Gastrointest. Endosc. 2012; 75: 719-27.
191. Cho SJ, Choi IJ, Kim CG, et al., Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms. Endoscopy 2012; 44: 114-21.
192. Takeuchi T, Ota K, Harada S, et al., The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. BMC Gastroenterol. 2013; 13: 136.
193. Goto O, Fujishiro M, Kodashima S, et al., A second-look endoscopy after endoscopic submucosal dissection for gastric epithelial neoplasm may be unnecessary: a retrospective analysis of postendoscopic submucosal dissection bleeding. Gastrointest. Endosc. 2010; 71: 241-8.
194. Goto O, Fujishiro M, Oda I, et al., A multicenter survey of the management after gastric endoscopic submucosal dissection related to postoperative bleeding. Dig. Dis. Sci. 2012; 57: 435-9.
195. Ryu HY, Kim JW, Kim HS, et al., Second-look endoscopy is not associated with better clinical outcomes after gastric endoscopic submucosal dissection: a prospective, randomized, clinical trial analyzed on an as-treated basis. Gastrointest. Endosc. 2013; 78: 285-94.
196. Mochizuki S, Uedo N, Oda I, et al., SAFE Trial Study Group. Scheduled second-look endoscopy is not recommended after endoscopic submucosal dissection for gastric neoplasms (the SAFE trial): a multicenter prospective randomised controlled non-inferiority trial. Gut 2015; 64: 397-405.
197. Watanabe Y, Kato N, Maehata T, et al., Safer endoscopic gastric mucosal resection: preoperative proton pump inhibitor administration. J. Gastroenterol. Hepatol. 2006; 21: 1675-80.
198. Ono S, Kato M, Ono Y, et al., Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial. Endoscopy 2009; 41: 299-303.
199. Tanimura S, Higashino M, Fukunaga Y, et al., Laparoscopic distal gastrectomy with regional lymph node dissection for gastric cancer. Surg. Endosc. 2005; 19: 1177-81.
200. Hori S, Ochiai T, Gunji Y, et al., A prospective randomized trial of hand-sutured versus mechanically stapled anastomoses for gastroduodenostomy after distal gastrectomy. Gastric Cancer 2004; 7: 24-30.
201. Yang HK, Lee HJ, Ahn HS, et al., Safety of modified double-stapling end-to-end gastroduodenostomy in distal subtotal gastrectomy. J. Surg. Oncol. 2007; 96: 624-9.
202. Pedrazzani C, Marrelli D, Rampone B, et al., Postoperative complications and functional results after subtotal gastrectomy with Billroth II reconstruction for primary gastric cancer. Dig. Dis. Sci. 2007; 52: 1757-63.
203. Tanizawa Y, Bando E, Kawamura T, et al., Early postoperative anastomotic hemorrhage after gastrectomy for gastric cancer. Gastric Cancer 2010; 13: 50-7.
204. Aoyama T, Yoshikawa T, Shirai J, et al., Investigation for anastomotic bleeding after gastric surgery. Cancer and Chemotherapy 2012; 39: 2298-300 (in Japanese).
205. Umano Y, Horiuchi T, Inoue M, et al., Endoscopic microwave coagulation therapy of postoperative hemorrhage from a stapled anastomosis. Hepatogastroenterology 2005; 52: 1768-70.
206. Nguyen NT, Longoria M, Chalifoux S, et al., Gastrointestinal hemorrhage after laparoscopic gastric bypass. Obes. Surg. 2004; 14: 1308-12.
207. Dulai GS, Jensen DM, Kovacs TO, et al., Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy 2004; 36: 68-72.
208. Chaves DM, Sakai P, Oliveira CV, et al., Watermelon stomach: clinical aspects and treatment with argon plasma coagulation. Arq. Gastroenterol. 2006; 43: 191-5.
209. Kjeldsen AD, Kjeldsen J,. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am. J. Gastroenterol. 2000; 95: 415-8.
210. Longacre AV, Gross CP, Gallitelli M, et al., Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am. J. Gastroenterol. 2003; 98: 59-65.
211. Chang YT, Wang HP, Huang SP, et al., Clinical application of argon plasma coagulation in endoscopic hemostasis for non-ulcer non-variceal gastrointestinal bleeding-a pilot study in Taiwan. Hepatogastroenterology 2002; 49: 441-3.
212. Roman S, Saurin JC, Dumortier J, et al., Tolerance and efficacy of argon plasma coagulation for controlling bleeding in patients with typical and atypical manifestations of watermelon stomach. Endoscopy 2003; 35: 1024-8.
213. Sebastian S, McLoughlin R, Qasim A, et al., Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia (watermelon stomach): long-term results. Dig. Liver Dis. 2004; 36: 212-7.
214. Kwan V, Bourke MJ, Williams SJ, et al., Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions: experience in 100 consecutive patients with long-term follow-up. Am. J. Gastroenterol. 2006; 101: 58-63.
215. Nakamura S, Mitsunaga A, Konishi M, et al., Longterm follow up of gastric antral vascular ectasia treated by argon plasma coagulation. Dig. Endosc. 2006; 18: 128-33.
216. Herrera S, Bordas JM, Llach J, et al., The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage. Gastrointest. Endosc. 2008; 68: 440-6.
217. Dray X, Camus M, Coelho J, et al., Treatment of gastrointestinal angiodysplasia and unmet needs. Dig. Liver Dis. 2011; 43: 515-22.
218. Sasamoto T, Tanaka A, Ishii T, et al., Argon plasma coagulation for bleeding from diffuse antral vascular ectasia in HCV related liver cirrhosis. Gastroenterol. Endosc. 2006; 48: 1139-43 (in Japanese).
219. Imai Y, Mizuno Y, Yoshino K, et al., Long-term efficacy of endoscopic coagulation for different types of gastric vascular ectasia. World J. Gastroenterol. 2013; 19: 2799-805.
220. Tominaga N, Yamaguchi D, Ogata S,. Soft coagulation for the treatment in angioectasia. Gastroenterol. Endosc 2011; 53: 3566-7 (in Japanese).
221. Wells CD, Harrison ME, Gurudu SR, et al., Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest. Endosc. 2008; 68: 231-6.
222. Keohane J, Berro W, Harewood GC, et al., Band ligation of gastric antral vascular ectasia is a safe and effective endoscopic treatment. Dig. Endosc. 2013; 25: 392-6.
223. Sato T, Yamazaki K, Akaike J,. Endoscopic band ligation versus argon plasma coagulation for gastric antral vascular ectasia associated with liver diseases. Dig. Endosc. 2012; 24: 237-42.
224. Junquera F, Feu F, Papo M, et al., A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 2001; 121: 1073-9.
225. Ge ZZ, Chen HM, Gao YJ, et al., Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation. Gastroenterology 2011; 141: 1629-37.
226. Junquera F, Saperas E, Videla S, et al., Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Am. J. Gastroenterol. 2007; 102: 254-60.
227. Fujishiro M, Iguchi M, Kakushima N, et al., Guidelines for endoscopic managements of non-variceal upper gastrointestinal bleeding. Gastroenterol. Endosc. 2015; 57: 1648-66 (in Japanese).